Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02862964 · ClinicalTrials.gov registry record

Accuro Versus Traditional Landmark Palpation Technique to Determine Accurate Spinal Level for Procedures

A clinical trial, sponsored by University of Virginia.

Completed
Registry status
106
Enrollment target

NCT02862964 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 106 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02862964 has completed, sponsored by University of Virginia.

COMPLETED
Registry status
106 participants
Enrollment target

Study Summary

Currently, at UVA, handheld ultrasound devices (like those used to view an unborn baby) are only two dimensional. The Accuro is a three dimensional handheld ultrasound device. This device uses sound waves to create pictures of the spine in three dimensions. This may allow the physician to view the spine in more detail for procedures such as spinal anesthesia and other diagnostic procedures. The investigators aim to assess the benefit of using the Accuro versus traditional landmark palpation technique to determine accurate spinal level for procedures. Patients who undergo interventional pain procedure per standard care under fluoroscopy and require the presence of an anesthesia provider at the UVA Pain Management Clinic will be approached for enrollment. Anesthesia Providers will first identify the L4/L5 space using the traditional technique of palpating the iliac crests to estimate spinal level, which will be marked with a single dot from a marking pen. The provider will then use the Accuro 3000 to identify the L4/L5 interspace and mark this point with two dots. Participants will then be taken into the fluoroscopy suite for their scheduled procedure. Since the skin marks will not show up on fluoroscopy, and metal instrument will be laid on the skin at the interspace or interspaces that were marked using the palpation and Accuro techniques. The anesthesiology attending provider in the fluoroscopy suite will then confirm the true interspace position of these marks under fluoroscopy. It will then be recorded how many spaces off the palpation and Accuro techniques are from the intended L4/L5 level.

Interventions

  • OTHER identify L4/L5

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2016-02
Est. Completion 2017-06-30

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT02862964

The ClinicalTrials.gov registry entry for NCT02862964 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which identify L4/L5 is the first listed.

NCT02862964 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02862964 about?

NCT02862964 is a clinical study titled "Accuro Versus Traditional Landmark Palpation Technique to Determine Accurate Spinal Level for Procedures". Currently, at UVA, handheld ultrasound devices (like those used to view an unborn baby) are only two dimensional. The Accuro is a three dimensional handheld ultrasound device. This device uses sound waves to create pictures of the spine in three dimensions. This may allow the physician to view the s...

What is the current status of trial NCT02862964?

This trial is currently completed. The enrollment target is 106 participants. The study started on 2016-02. Estimated completion is 2017-06-30.

What interventions are being tested in trial NCT02862964?

The interventions under investigation include: identify L4/L5 (OTHER).

Who is sponsoring clinical trial NCT02862964?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.